 |
½ÅÀç±¹
|
½º¸¶Æ® ½Å¾à°³¹ßÀ» À§ÇÑ in vitro ADME (ÃÊû°¿¬ )
|
|
´ë±¸°æºÏ÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü ½Å¾à°³¹ßÁö¿ø¼¾ÅÍ / ½Å¾à°³¹ßÁö¿ø¼¾ÅÍ (5Ãþ ´ëȸÀǽÇ) / 2025.01.15 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
Center for Personalized Medicine of Tuberculosis(CPMTB) : Status and Perspectives (ÃÊû°¿¬ )
|
|
2024 °áÇÙ ¿¬±¸ ½ÉÆ÷Áö¾ö / Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø / 2024.12.11 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
In vitro ADME study for PBPK modeling in MIDD/MIPD (ÃÊû°¿¬ )
|
|
2024 Forum on Innovative Technologies in Drug Development and Talent Training / Fudan University, China / 2024.11.01 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
Model Informed Precision Dosing and the Semi-automated TDM for Personalized Medicine of Antituberculosis Drugs (±¸µÎ¹ßÇ¥ )
|
|
Respiratory Infections Seminar: Tuberculosis / Australia-University of Queensland / 2024.10.17 (online) [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
In vitro ADME studies and PBPK model-informed drug development (ÃÊû°¿¬ )
|
|
Certara Certainty Korea 2024 / Certara Kora / 2024.09.10 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
Global progress in PGx (ÃÊû°¿¬ )
|
|
Conference Room , Institute of Clinical Pharmacology, Xiangya Hospital of Central South University / China Chansha / 2024.05.28 - 05.30 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
¾à¹°À¯ÀüüÇÐ ±â¹Ý ¸ÂÃã¾à¹°Ä¡·á ÀÓ»óÀû¿ë (ÃÊû°¿¬ )
|
|
2024Çг⵵ ¾àÇבּ¸¼Ò ¹× ·¥ÇÁ »ç¾÷´Ü ÃÊû¼¼¹Ì³ª / Á¶¼±´ëÇб³ ¾àÇдëÇб³ / 2024.05.23 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
Model Informed Precision Dosing and Semi-automated TDM for Personalized Medicine of Antituberculosis Drugs (ÃÊû°¿¬ )
|
|
APRC 2024_The 9th Asia Pacific Region conference of the international Union Against Tuberculosis and Lung Disease / Taipei International Convention Center (TICC) / 2024.04.27 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
In vitro ADME research for smart new drug development (ÃÊû°¿¬ )
|
|
2024 ´ëÇѾàÇÐȸ Ãá°è±¹Á¦Çмú´ëȸ / ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ / 2024.04.19 [LINK ] |
|
 |
|
|
 |
Á¶¿ë¼ø
|
|
Myanmar-Korea Joint Symposium / 2024.01.24 [LINK ] |
|
 |
|